Skip to main content
Premium Trial:

Request an Annual Quote

Potato Genome Project to Kick Off with Funding from Dutch Government

NEW YORK, March 31 (GenomeWeb News) - The Potato Genome Sequencing Consortium said today that the Dutch government has awarded it €3 million ($3.6 million) to begin sequencing the first potato chromosome.


The PGSC said it aims to complete the sequencing of the potato genome by the end of 2010.


The PGSC is an initiative of the Netherlands Genomics Initiative and the WageningenUniversity and ResearchCenter, and includes research teams from Brazil, Chile, Peru, Canada, the United States, Denmark, France, Ireland, Poland, Turkey, the UK, the Russian Federation, India, China, and New Zealand.


WageningenUniversityis coordinating the sequencing effort will maintain the potato genome database. Researchers at the university have already developed DNA libraries for the consortium partners and a map of the twelve potato chromosomes.


The funding from the Dutch government will support the sequencing of chromosome 1 and the coordination of the consortium.


PGSC said that access to the complete genome sequence of the potato -- the world's fourth largest crop -- will enable the development of new varieties with higher disease resistance and improved nutritional quality.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.